Oncology Search
Oncology Oncology

Podcast: Dr Dennis Slamon says MONALEESA-3 supports the potential of CDK4/6 inhibitors in the first-line setting for HR+/HER2- breast cancer

11 Oct 2019
Podcast: Dr Dennis Slamon says MONALEESA-3 supports the potential of CDK4/6 inhibitors in the first-line setting for HR+/HER2- breast cancer
Editor's Recommendations